SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-053706
Filing Date
2024-04-29
Accepted
2024-04-29 12:30:27
Documents
13
Period of Report
2024-04-29
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2412956d1_8k.htm   iXBRL 8-K 28393
  Complete submission text file 0001104659-24-053706.txt   201660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbio-20240429.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20240429_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20240429_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2412956d1_8k_htm.xml XML 3561
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 24888588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)